Basics Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure. IPO Date: March 1, 2007 Sector: Healthcare Industry: Biotech Market Cap: $466.68M Activated in VL: True Average Daily Range Avg Daily Range: $0.17 | 3.93% Avg Daily Range (30 D): $0.60 | 6.10% Avg Daily Range (90 D): $0.62 | 5.34% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): 2.52M Avg Daily Volume (90 D): 1.68M Trade Size Avg Trade Size (Sh.): 203 Avg Trade Size (Sh.) (30 D): 114 Avg Trade Size (Sh.) (90 D): 97 Institutional Trades Total Inst.Trades: 270 Avg Inst. Trade: $1.39M Avg Inst. Trade (30 D): $1.04M Avg Inst. Trade (90 D): $1.14M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.52M Avg Closing Trade (30 D): $1.09M Avg Closing Trade (90 D): $1.2M Avg Closing Volume: 126.83K     News Jun 2, 2025 @ 5:55 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A May 16, 2025 @ 10:36 PM CAPR Investors Have Opportunity to Join Capricor T... Source: Business Wire May 9, 2025 @ 2:53 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A May 9, 2025 @ 2:47 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A Feb 21, 2025 @ 6:00 PM Cell and Gene Therapies in Rare Disorders Market t... Source: Delveinsight Financials   TTM Q4 2024 FY 2024 Basic EPS $-.53 $-.11 $-1.15 Diluted EPS $-.53 $-.11 $-1.15 Revenue $ M $ 11.13M $ 22.27M Gross Profit $ $ $ Net Income / Loss $ -24.39M $ -7.12M $ -40.47M Operating Income / Loss $ -24.98M $ -7.7M $ -42.56M Cost of Revenue $ $ $ Net Cash Flow $ 17.51M $ -57.09M $ -3.41M PE Ratio     Splits Jun 05, 2019:   1:10 Nov 21, 2013:   1:50 Feb 09, 2007:   1:10 Apr 05, 2005:   1:20